Anxiety Disorders

• FDA label_change · 2023-01-17
  FDA Approved: CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Micro Labs Limited)

  The FDA approved a supplemental application for the fixed-dose combination chlordiazepoxide and amitriptyline hydrochloride from Micro Labs …

• FDA label_change · 2021-02-05
  FDA Approved: ATIVAN — Supplemental Application (Bausch Health US LLC)

  The FDA approved a supplemental application for ATIVAN (lorazepam) submitted by Bausch Health US LLC, resulting in a labeling change for the…

• FDA label_change · 2008-09-10
  FDA Approved: LORAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for Lorazepam from Teva Pharmaceuticals USA, Inc.

• FDA label_change · 2008-08-05
  FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for Hydroxyzine Hydrochloride (Teva Pharmaceuticals USA, Inc.), updating the labeling.